Litigation Against Opioid Manufacturers: Lessons from the Tobacco Wars
March 15, 2018
Dozens of state, local, and tribal governments have sued opioid pain reliever manufacturers for their alleged role in fueling the opioid overdose epidemic, and 41 state attorneys general are investigating potential unlawful sales and marketing practices by these manufacturers. Although these investigations and lawsuits appear similar to those against the tobacco industry during the 1990s, states should mindful of the important ways in which they differ.
View/download the Presentation Slides
By attending this webinar, you will:
- Learn about how differences in the regulatory environment for OPRs versus cigarettes might impact efforts to reduce opioid related morbidity and mortality.
- Understand both the successes and shortcomings of the tobacco litigation, including unintended consequences that negatively affected efforts to reduce tobacco-related harm.
- Learn why a Master Settlement Agreement similar to the one that resulted from the tobacco litigation may not be the most effective solution for reducing opioid related harm.
- Hector Hernandez-Delgado, Staff Attorney, National Health Law Program
- Corey S. Davis, JD, MSPH, Deputy Director and Staff Attorney, The Network for Public Health Law – Southeastern Region Office and Senior Attorney at the National Health Law Program
- Derek Carr, JD, Fellow, The Network for Public Health Law
- Lainie Rutkow, JD, PhD, MPH, Associate Professor, Johns Hopkins Bloomberg School of Public Health
You may qualify for CLE credit. ASLME is an approved provider of continuing legal education credits in several states ASLME will also apply for CLE credits in other states upon request. An email from ASLME regarding CLE credits will be sent to attendees following the webinar.